The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
using CP as an example they happen to have a CP uh you know mutation or a CP variant that offers remark protection against atherosclerosis of which an interesting but kind of irrelevant phenotype is high HDL cholesterol and that's offsetting the damage of their LP little a
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
or that H they're protected by other longevity Gene and it makes it irrelevant what this LP although I don't think those are mutually exclusive